Pharmacies to have expanded role in cancer diagnosis
In Health & NHS
Follow this topic
Bookmark
Record learning outcomes
Community pharmacies will have an “expanded role” in cancer diagnosis, says the Government in its national cancer plan. This will include offering “first-line tests” for possible cancer symptoms.
The plan outlines an ambition to deliver an additional 9.5 million diagnostic tests by 2029, backed by funding of £2.3bn, enabling patients to access early test appointments, including from community diagnostic centres with extended-hours opening.
An individual cancer plan is to be offered to every patient as well as a personal needs assessment.
The plan sets a target of 75 per cent of patients diagnosed from 2035 to be cancer-free or living well after five years. Currently, 60 per cent of patients survive for five years or more.
NPA chief executive Henry Gregg welcomed the several mentions of community pharmacy in the plan, saying the sector is a “massive untapped resource” to help detect serious illnesses such as cancer early on, “which we know greatly improves survival rates for many cancers”.
“With more pharmacies in more deprived areas, pharmacies can help drive [vaccination] uptake especially amongst underserved communities. Commissioning pharmacies to deliver more NHS vaccines … would release GP capacity and drive vaccine uptake,” he said.
However, Dr Thayer warned that any newly commissioned vaccination programmes would require additional investment on top of wider efforts to close pharmacy’s funding gap.